TEAS Plus New Application

PTO- 1478

Approved for use through 10/31/2024. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1478

Approved for use through 10/31/2024. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 98143296

Filing Date: 08/21/2023

To the Commissioner for Trademarks:

MARK: S D (stylized and/or with design, see mark)
The literal element of the mark consists of S D. The applicant is not claiming color as a feature of the mark. The mark consists of a pill capsule outline that is shaped like the letter S, with eyes and ears on the top half of the capsule, and the bottom half of the capsule resembling the letter D pointed downward.
The applicant, Single Dose Therapeutics, LLC, DBA Single Dose, a limited liability company legally organized under the laws of California, having an address of
      Ste 100-387
      446 Old County Rd
      Pacifica, California 94044
      United States
      650-665-9663?(phone)
      XXXXand a domicile address of       XXXX
      XXXX, XXXX XXXX
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 042:  Pharmaceutical research and development

Use in Commerce: The applicant is using the mark in commerce on or in connection with the identified goods/services. The applicant attaches, or will later submit, one specimen as a JPG/PDF image file showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, regardless of whether the mark itself is in the standard character format or is a stylized or design mark. The specimen image file may be in color, and the image must be in color if color is being claimed as a feature of the mark.

In International Class 042, the mark was first used by the applicant or the applicant's related company or licensee predecessor in interest at least as early as 10/25/2022, and first used in commerce at least as early as 10/25/2022, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Contact page of the Single Dose Therapeutics website which shows the service mark and descriptions of the pharmaceutical research and development services provided..
Specimen File1

Webpage URL: http://www.singledose.one/
Webpage Date of Access: 07/16/2023



For informational purposes only, applicant's website address is: http://www.singledose.one/

The applicant's current Correspondence Information:

Single Dose Therapeutics, LLC

PRIMARY EMAIL FOR CORRESPONDENCE: info@singledose.one        SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): davin@singledose.one Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $250 has been submitted with the application, representing payment for 1 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Davin Rautiola/   Date: 08/21/2023
Signatory's Name: Davin Rautiola
Signatory's Position: Principal
Signatory's Phone Number: 650-665-9663
Signature method: Signed directly within the form
Payment Sale Number: 98143296
Payment Accounting Date: 08/21/2023

Serial Number: 98143296
Internet Transmission Date: Mon Aug 21 19:39:22 ET 2023
TEAS Stamp: USPTO/FTK-XX.XXX.XX.XX-20230821193923538
384-98143296-860b9a872d9fa616ec93837ea6c
844b9bae0bbe7a715b355f40e4f8aae9d8fc-CC-
39229509-20230821171011993651